- Home
- TCBI vs INDV Comparison
TCBI vs INDV Comparison
Compare TCBI & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TCBI | INDV |
|---|---|---|
| Founded | 1996 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.7B |
| IPO Year | 2000 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TCBI | INDV |
|---|---|---|
| Price | $98.30 | $36.87 |
| Analyst Decision | Hold | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $100.92 | N/A |
| AVG Volume (30 Days) | 421.9K | ★ 2.4M |
| Earning Date | 04-23-2026 | 06-08-2026 |
| Dividend Yield | ★ 0.81% | N/A |
| EPS Growth | 430.47 | ★ 8100.00 |
| EPS | ★ 3.39 | 1.67 |
| Revenue | $149,000.00 | ★ $1,239,000,000.00 |
| Revenue This Year | $14.76 | N/A |
| Revenue Next Year | $7.47 | N/A |
| P/E Ratio | $28.92 | ★ $22.62 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $75.41 | $22.22 |
| 52 Week High | $108.92 | $42.81 |
Technical Indicators
Market Signals| Indicator | TCBI | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 42.00 | 37.17 |
| Support Level | $96.97 | $35.49 |
| Resistance Level | $102.57 | $38.08 |
| Average True Range (ATR) | 1.52 | 1.41 |
| MACD | -0.14 | -0.13 |
| Stochastic Oscillator | 18.93 | 26.18 |
Price Performance
Historical ComparisonAbout TCBI Texas Capital Bancshares Inc.
Texas Capital Bancshares Inc is a registered bank holding company and a full-service financial services firm that delivers customised solutions to businesses, entrepreneurs and individual customers. It is a secured lender with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. Texas Capital has established commercial banking, consumer banking, investment banking and wealth management capabilities.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).